Sendai virus recombinant vaccine expressing hPIV-3 HN or F elicits protective immunity and combines with a second recombinant to prevent hPIV-1, hPIV-3 and RSV infections

The human parainfluenza viruses (hPIVs) and Respiratory Syncytial Virus (RSV) are the leading causes of serious respiratory illness in the human pediatric population. Despite decades of research, there are currently no licensed vaccines for either the hPIV or RSV pathogens. Here we describe the test...

Полное описание

Сохранить в:
Библиографические подробности
Главные авторы: Zhan, Xiaoyan, Slobod, Karen S., Krishnamurthy, Sateesh, Luque de Johnson, Laura E., Takimoto, Toru, Jones, Bart, Surman, Sherri, Russell, Charles, Portner, Allen, Hurwitz, Julia L.
Формат: Artigo
Язык:Inglês
Опубликовано: 2008
Предметы:
Article
Online-ссылка:https://ncbi.nlm.nih.gov/pmc/articles/PMC2728217/
https://ncbi.nlm.nih.gov/pubmed/18499307
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.vaccine.2008.04.022
Метки: Добавить метку
Нет меток, Требуется 1-ая метка записи!

Схожие документы